RhumbLine Advisers
REPL icon

RhumbLine Advisers’s Replimune Group REPL Stock Holding History

RhumbLine Advisers’s Portfolio REPL Stock Details REPL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$671K Sell
87,740
-1,571
-2% -$12K ﹤0.01% 2427
2025
Q4 		$868K Sell
89,311
-10,004
-10% -$85K ﹤0.01% 2313
2025
Q3 		$416K Sell
99,315
-2,690
-3% -$17.2K ﹤0.01% 2817
2025
Q2 		$948K Buy
102,005
+6,616
+7% +$57.7K ﹤0.01% 2278
2025
Q1 		$930K Sell
95,389
-76
-0.1% -$941 ﹤0.01% 2206
2024
Q4 		$1.16M Buy
95,465
+7,317
+8% +$88.9K ﹤0.01% 2176
2024
Q3 		$966K Buy
88,148
+3,225
+4% +$32.8K ﹤0.01% 2281
2024
Q2 		$764K Buy
84,923
+5,732
+7% +$40K ﹤0.01% 2393
2024
Q1 		$647K Buy
79,191
+2,026
+3% +$16.6K ﹤0.01% 2505
2023
Q4 		$650K Buy
77,165
+6,621
+9% +$76.8K ﹤0.01% 2507
2023
Q3 		$1.21M Buy
70,544
+939
+1% +$18.4K ﹤0.01% 2101
2023
Q2 		$1.62M Sell
69,605
-3,828
-5% -$74.8K ﹤0.01% 2025
2023
Q1 		$1.3M Buy
73,433
+10,770
+17% +$256K ﹤0.01% 2017
2022
Q4 		$1.7M Buy
62,663
+3,685
+6% +$76.6K ﹤0.01% 1863
2022
Q3 		$1.02M Buy
58,978
+14,971
+34% +$285K ﹤0.01% 2123
2022
Q2 		$769K Buy
44,007
+11,364
+35% +$187K ﹤0.01% 2268
2022
Q1 		$554K Buy
32,643
+1,616
+5% +$30.5K ﹤0.01% 2381
2021
Q4 		$841K Buy
31,027
+368
+1% +$11K ﹤0.01% 2276
2021
Q3 		$909K Buy
30,659
+2,206
+8% +$71.6K ﹤0.01% 2264
2021
Q2 		$1.09M Buy
28,453
+4,835
+20% +$165K ﹤0.01% 2208
2021
Q1 		$721K Sell
23,618
-1,135
-5% -$42.5K ﹤0.01% 2327
2020
Q4 		$944K Buy
24,753
+5,389
+28% +$225K ﹤0.01% 2158
2020
Q3 		$446K Sell
19,364
-1,068
-5% -$24.3K ﹤0.01% 2337
2020
Q2 		$508K Buy
20,432
+5,009
+32% +$88.6K ﹤0.01% 2338
2020
Q1 		$154K Buy
15,423
+525
+4% +$7.83K ﹤0.01% 2665
2019
Q4 		$214K Buy
14,898
+365
+3% +$5.26K ﹤0.01% 2725
2019
Q3 		$202K Sell
14,533
-135
-0.9% -$1.66K ﹤0.01% 2743
2019
Q2 		$215K Buy
14,668
+3,253
+28% +$47K ﹤0.01% 2766
2019
Q1 		$174K Buy
+11,415
New +$142K ﹤0.01% 2778

Other funds holding REPL

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

RhumbLine Advisers's REPL Position: Q1 2026 in Review

RhumbLine Advisers reduced its Replimune Group (REPL) stake by 1.8% in Q1 2026, selling an estimated $12K and leaving 87,740 shares worth $671K. The position accounts for ﹤0.01% of the portfolio, ranked #2427.

RhumbLine Advisers first reported a position in REPL in Q1 2019 and has held it in 29 quarters since. The position peaked at $1.7M in Q4 2022. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • RhumbLine Advisers held 87,740 shares of Replimune Group worth $671K as of Q1 2026.
  • RhumbLine Advisers sold 1,571 Replimune Group shares in Q1 2026, an estimated $12K.
  • Replimune Group made up ﹤0.01% of RhumbLine Advisers's portfolio in Q1 2026, its #2427 holding.
  • RhumbLine Advisers first reported a position in Replimune Group in Q1 2019 and has held it in 29 quarters since.
  • RhumbLine Advisers's Replimune Group position peaked at $1.7M in Q4 2022.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.